377 related articles for article (PubMed ID: 9449529)
1. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
Nair MP; Schwartz SA
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of cortisol and HIV-1 envelope peptide on the NK activities of normal lymphocytes.
Nair MP; Schwartz SA
Brain Behav Immun; 1995 Mar; 9(1):20-30. PubMed ID: 7620208
[TBL] [Abstract][Full Text] [Related]
3. Selective effect of alcohol on cellular immune responses of lymphocytes from AIDS patients.
Nair MP; Kumar NM; Kronfol ZA; Saravolatz LA; Pottathil R; Greden JF; Schwartz SA
Alcohol; 1994; 11(2):85-90. PubMed ID: 8204207
[TBL] [Abstract][Full Text] [Related]
4. Reversal of human immunodeficiency virus type 1 protein-induced inhibition of natural killer cell activity by alpha interferon and interleukin-2.
Nair MP; Schwartz SA
Clin Diagn Lab Immunol; 2000 Jan; 7(1):101-5. PubMed ID: 10618286
[TBL] [Abstract][Full Text] [Related]
5. Stable expression of the transfected HIV-1 env gene in a human B cell line: characterization of gp120-expressing clones and immunobiological studies.
Ahmad A; Ladha A; Cohen EA; Menezes J
Virology; 1993 Feb; 192(2):447-57. PubMed ID: 8421893
[TBL] [Abstract][Full Text] [Related]
6. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
Bonavida B; Katz J; Gottlieb M
J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
[TBL] [Abstract][Full Text] [Related]
8. Loss of T-cell cytotoxic responses in the course of HIV-1 infection.
Zerhouni B; Sanhadji K; Touraine JL
Thymus; 1997; 24(4):203-19. PubMed ID: 9493284
[TBL] [Abstract][Full Text] [Related]
9. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
Nair MP; Schwartz SA
J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
[TBL] [Abstract][Full Text] [Related]
11. Recombinant proteins derived from immunodominant regions of the gag and env genes of HIV-1 and their potential for use in serologic diagnosis.
Kovác J
Acta Virol; 1991 Aug; 35(4):383-90. PubMed ID: 1686963
[TBL] [Abstract][Full Text] [Related]
12. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.
Harris DT; Cianciolo GJ; Snyderman R; Argov S; Koren HS
J Immunol; 1987 Feb; 138(3):889-94. PubMed ID: 2433333
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection.
Fehniger TA; Herbein G; Yu H; Para MI; Bernstein ZP; O'Brien WA; Caligiuri MA
J Immunol; 1998 Dec; 161(11):6433-8. PubMed ID: 9834136
[TBL] [Abstract][Full Text] [Related]
16. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
Denner J; Norley S; Kurth R
AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
[TBL] [Abstract][Full Text] [Related]
17. Bacterially expressed core and envelope proteins of human immunodeficiency virus type-1 (HIV-1): comparative evaluation in detection of type-specific antibodies.
Kovác J; Zachar V; Brůcková M; Ujhélyi E; Füst G; Mayer V; Zajac V
Acta Virol; 1992 Aug; 36(4):337-46. PubMed ID: 1282776
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes.
Nair MP; Pottathil R; Heimer EP; Schwartz SA
Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6498-502. PubMed ID: 3045818
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 restores natural killer activity inhibited by sera from HIV+ hemophilic patients.
Vulcano M; Galassi N; Felippo M; Vernava D; Olabuenaga S
Medicina (B Aires); 1999; 59(2):162-6. PubMed ID: 10413894
[TBL] [Abstract][Full Text] [Related]
20. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
